Marisa Montes

3.4k total citations · 1 hit paper
87 papers, 1.6k citations indexed

About

Marisa Montes is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Marisa Montes has authored 87 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Epidemiology, 34 papers in Hepatology and 28 papers in Infectious Diseases. Recurrent topics in Marisa Montes's work include Hepatitis C virus research (32 papers), Liver Disease Diagnosis and Treatment (30 papers) and HIV-related health complications and treatments (28 papers). Marisa Montes is often cited by papers focused on Hepatitis C virus research (32 papers), Liver Disease Diagnosis and Treatment (30 papers) and HIV-related health complications and treatments (28 papers). Marisa Montes collaborates with scholars based in Spain, United States and United Kingdom. Marisa Montes's co-authors include José Ramón Arribas, Juan González‐García, Federico Pulido, Juan Berenguer, Al Romero, Enrique M. Ostrea, Paul E. Sax, Andrew Cheng, Pilar Miralles and Devi SenGupta and has published in prestigious journals such as The Lancet, Blood and PLoS ONE.

In The Last Decade

Marisa Montes

80 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial

2017 278 citations Marisa Montes et al. profile →

Peers

Marisa Montes

EPIDE

VIROL

HEPAT

David Zucman France

Ignacio de los Santos Spain

M. Leal Spain

Shyamasundaran Kottilil United States

Yang Han China

Stephen Raffanti United States

Laura Sighinolfi Italy

G Scullard United Kingdom

Sara Ferrando‐Martínez Spain

Alessandro Cozzi‐Lepri United Kingdom

David Zucman France

Marisa Montes

589 ×0.7

369 ×0.6

EPIDE

301 ×0.5

VIROL

165 ×0.4

205 ×0.5

HEPAT

Citations per year, relative to Marisa Montes Marisa Montes (= 1×) peers David Zucman

Countries citing papers authored by Marisa Montes

Since Specialization

Citations

This map shows the geographic impact of Marisa Montes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marisa Montes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marisa Montes more than expected).

Fields of papers citing papers by Marisa Montes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marisa Montes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marisa Montes. The network helps show where Marisa Montes may publish in the future.

Co-authorship network of co-authors of Marisa Montes

This figure shows the co-authorship network connecting the top 25 collaborators of Marisa Montes. A scholar is included among the top collaborators of Marisa Montes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marisa Montes. Marisa Montes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chafino, Sílvia, Laura Tarancón‐Díez, Sonia Alcolea, et al.. (2025). Metabolomics for searching non-invasive biomarkers of metabolic dysfunction-associated steatotic liver disease in youth with vertical HIV. Communications Medicine. 5(1). 433–433. 1 indexed citations

Troya, Jesús, Marisa Montes, Juan Emilio Losa, & Luís Buzón. (2025). Long-Acting CAB Plus RPV: It's Not About Weight, It's About the Weight of the Evidence. Clinical Infectious Diseases. 81(2). e33–e34.

Montes, Marisa, Carmen Busca, Núria Espinosa, et al.. (2024). Incidence of Diabetes Mellitus and Associated Factors in the Era of Antiretroviral Drugs With a Low Metabolic Toxicity Profile. Open Forum Infectious Diseases. 11(4). ofae112–ofae112. 4 indexed citations

Buckley, Rosa de Miguel, Carmen Busca, Rafael Micán, et al.. (2024). Sex differences in the effectiveness and tolerability of dolutegravir plus rilpivirine as a switch strategy in people living with HIV. HIV Medicine. 25(6). 684–691.

Navarro, Jordi, Adrián Curran, Berta Raventós, et al.. (2023). Prevalence of non-alcoholic fatty liver disease in a multicentre cohort of people living with HIV in Spain.. European Journal of Internal Medicine. 110. 54–61. 6 indexed citations

Martínez‐Sanz, Javier, Juan M. Rodrı́guez, Claudio Alba, et al.. (2023). A gut microbiome signature for HIV and metabolic dysfunction-associated steatotic liver disease. Frontiers in Immunology. 14. 1297378–1297378. 11 indexed citations

Busca, Carmen, Ángel Robles‐Marhuenda, Mariana Díaz‐Almirón, et al.. (2023). Prevalence and Temporal Trends of Autoimmune Diseases in People Living with HIV. AIDS Research and Human Retroviruses. 39(3). 130–135. 2 indexed citations

Palacios, Rosario, Cristina Gómez‐Ayerbe, José L. Casado, et al.. (2023). Efficacy and safety of dolutegravir/rilpivirine in real‐world clinical practice. GeSIDA study 1119. HIV Medicine. 24(8). 933–937. 3 indexed citations

Brañas, Fátima, Miguel Torralba, Antonio Antela, et al.. (2023). Effects of frailty, geriatric syndromes, and comorbidity on mortality and quality of life in older adults with HIV. BMC Geriatrics. 23(1). 4–4. 19 indexed citations

10.

Moreno, Elena, Javier Martínez‐Sanz, Rosa Martín‐Mateos, et al.. (2023). Global DNA methylation and telomere length as markers of accelerated aging in people living with HIV and non-alcoholic fatty liver disease. BMC Genomics. 24(1). 567–567. 2 indexed citations

11.

Martínez‐Sanz, Javier, María V. Calvo, Sergio Serrano‐Villar, et al.. (2022). Effects of HIV Infection in Plasma Free Fatty Acid Profiles among People with Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine. 11(13). 3842–3842. 6 indexed citations

12.

Díaz‐Almirón, Mariana, Carmen Busca, Rafael Micán, et al.. (2022). Change in metabolic parameters after switching from triple regimens with tenofovir alafenamide to dolutegravir‐based dual therapy. Bi‐lipid study. HIV Medicine. 24(5). 558–567. 2 indexed citations

13.

Busca, Carmen, Matilde Sánchez‐Conde, Eulalia Valencia, et al.. (2022). Assessment of Noninvasive Markers of Steatosis and Liver Fibrosis in Human Immunodeficiency Virus-Monoinfected Patients on Stable Antiretroviral Regimens. Open Forum Infectious Diseases. 9(7). ofac279–ofac279. 9 indexed citations

14.

Martı́n-Carbonero, Luz, Rosa de Miguel Buckley, Lucía Serrano‐Luján, et al.. (2022). Acute hepatitis B among HIV positive persons: A two-decade review of cases from a Spanish cohort. Enfermedades infecciosas y microbiologia clinica (English ed ). 40(3). 121–124. 1 indexed citations

15.

Busca, Carmen, et al.. (2021). Psoriasis and Liver Damage in HIV-Infected Patients. Cells. 10(5). 1099–1099. 2 indexed citations

16.

Medrano, Luz María, Juan González‐García, Juan Berenguer, et al.. (2020). Plasma IP-10 and IL-6 are linked to Child-Pugh B cirrhosis in patients with advanced HCV-related cirrhosis: a cross-sectional study. Scientific Reports. 10(1). 10384–10384. 7 indexed citations

17.

Pasquau, Juan, Carmen Hidalgo-Tenorio, Marisa Montes, et al.. (2018). High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial. PLoS ONE. 13(4). e0195068–e0195068. 30 indexed citations

18.

Montes, Marisa, José M. Miró, Carmen Quereda, et al.. (2013). Incidence of Hepatocellular Carcinoma in HIV-Infected Patients With Cirrhosis. JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(1). 82–86. 11 indexed citations

19.

Berenguer, Juan, Pilar Miralles, Josep‐María Ribera, et al.. (2008). Characteristics and Outcome of AIDS-Related Hodgkin Lymphoma Before and After the Introduction of Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(4). 422–428. 64 indexed citations

20.

Knobel, Hernando, José M. Miró, Beatriz Mahíllo, et al.. (2004). Failure of Cetirizine to Prevent Nevirapine-Associated Rash. JAIDS Journal of Acquired Immune Deficiency Syndromes. 37(2). 1276–1281. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact